Prediction of sarcopenia using a combination of multiple serum biomarkers

[1]  C. Cooper,et al.  Epidemiology of sarcopenia and insight into possible therapeutic targets , 2017, Nature Reviews Rheumatology.

[2]  J. Morley,et al.  Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code. , 2016, Journal of the American Medical Directors Association.

[3]  A. Bazzocchi,et al.  The role of DXA in sarcopenia , 2016, Aging Clinical and Experimental Research.

[4]  A. Kalinkovich,et al.  Sarcopenia – The search for emerging biomarkers , 2015, Ageing Research Reviews.

[5]  T. Bertsch,et al.  Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis? , 2015, Biogerontology.

[6]  W. Aoi,et al.  Current understanding of sarcopenia: possible candidates modulating muscle mass , 2015, Pflügers Archiv - European Journal of Physiology.

[7]  Dong-Hyung Cho,et al.  A nineteen gene‐based risk score classifier predicts prognosis of colorectal cancer patients , 2014, Molecular oncology.

[8]  F. Marini,et al.  Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older hip fractured patients , 2014, Experimental Gerontology.

[9]  M. Nishihara,et al.  [Transdisciplinary Approach for Sarcopenia. Molecular mechanism of sarcopenia : The role of skeletal muscle niche component SPARC in the regulation of myogenesis and adipogenesis and its alteration with age]. , 2014, Clinical calcium.

[10]  Jeffrey R Stout,et al.  Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS) , 2014, Age and ageing.

[11]  B. Spiegelman,et al.  Meteorin-like Is a Hormone that Regulates Immune-Adipose Interactions to Increase Beige Fat Thermogenesis , 2014, Cell.

[12]  Richard T. Lee,et al.  Restoring Systemic GDF11 Levels Reverses Age-Related Dysfunction in Mouse Skeletal Muscle , 2014, Science.

[13]  L. Panton,et al.  Interrelationship among muscle, fat, and bone: Connecting the dots on cellular, hormonal, and whole body levels , 2014, Ageing Research Reviews.

[14]  L. Peng,et al.  Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. , 2014, Journal of the American Medical Directors Association.

[15]  M. Nishihara,et al.  Loss of sparc in mouse skeletal muscle causes myofiber atrophy , 2013, Muscle & nerve.

[16]  Rikke C. Nørgaard,et al.  SPARC is up-regulated during skeletal muscle regeneration and inhibits myoblast differentiation. , 2013, Histology and histopathology.

[17]  J. Heineke,et al.  Finding good biomarkers for sarcopenia , 2012, Journal of cachexia, sarcopenia and muscle.

[18]  X. Wang,et al.  Sixty‐five gene‐based risk score classifier predicts overall survival in hepatocellular carcinoma , 2012, Hepatology.

[19]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[20]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[21]  V. Serre-Beinier,et al.  Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice. , 2010, The Journal of endocrinology.

[22]  M. Carreira,et al.  The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. , 2010, The Journal of endocrinology.

[23]  R. Dodel,et al.  Macrophage Migration Inhibitory Factor in Normal Human Skeletal Muscle and Inflammatory Myopathies , 2010, Journal of neuropathology and experimental neurology.

[24]  J. Baeyens,et al.  Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.

[25]  S. Anton,et al.  Molecular inflammation: Underpinnings of aging and age-related diseases , 2009, Ageing Research Reviews.

[26]  Susanne Thayssen,et al.  Secreted Protein Acidic and Rich in Cysteine (SPARC) in Human Skeletal Muscle , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[27]  Yuichi Akasaki,et al.  FGF21 is an Akt‐regulated myokine , 2008, FEBS letters.

[28]  M. Febbraio,et al.  Muscle as an endocrine organ: focus on muscle-derived interleukin-6. , 2008, Physiological reviews.

[29]  Albert Eric Schultze,et al.  Fabp3 as a biomarker of skeletal muscle toxicity in the rat: comparison with conventional biomarkers. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  G. Goldspink.  Loss of muscle strength during aging studied at the gene level. , 2007, Rejuvenation research.

[31]  N. Rosenthal,et al.  Local expression of IGF‐1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  M. Mcmurdo,et al.  Sarcopenia – A Potential Target for Angiotensin-Converting Enzyme Inhibition? , 2006, Gerontology.

[33]  Se-Jin Lee.  Regulation of muscle mass by myostatin. , 2004, Annual review of cell and developmental biology.

[34]  A. Bigot,et al.  IGF-1 induces human myotube hypertrophy by increasing cell recruitment. , 2004, Experimental cell research.

[35]  G. Yancopoulos,et al.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.

[36]  Luigi Ferrucci,et al.  Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. , 2003, Journal of applied physiology.

[37]  R. Ross,et al.  Estimation of skeletal muscle mass by bioelectrical impedance analysis. , 2000, Journal of applied physiology.

[38]  E. Sage,et al.  SPARC, a Matricellular Glycoprotein with Important Biological Functions , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[39]  W. Mayo,et al.  Ciliary Neurotrophic Factor is a Regulator of Muscular Strength in Aging , 1999, The Journal of Neuroscience.

[40]  I. Rosenberg,et al.  Sarcopenia: origins and clinical relevance. , 1997, The Journal of nutrition.

[41]  E. Sage,et al.  The biology of SPARC, a protein that modulates cell‐matrix interactions , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  H. Kleinman,et al.  Osteonectin, a bone-specific protein linking mineral to collagen , 1981, Cell.

[43]  Katsuhiko Suzuki,et al.  Cytokine expression and secretion by skeletal muscle cells: regulatory mechanisms and exercise effects. , 2015, Exercise immunology review.

[44]  D. Kiel,et al.  Procollagen type III N-terminal peptide (P3NP) and lean mass: a cross-sectional study. , 2013, The Journal of frailty & aging.

[45]  J. Baeyens,et al.  European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people , 2010 .

[46]  R. Roubenoff.  Sarcopenia: a major modifiable cause of frailty in the elderly. , 2000, The journal of nutrition, health & aging.

[47]  H. Hansson,et al.  Satellite cells express the trophic factor IGF-I in regenerating skeletal muscle. , 1987, Acta physiologica Scandinavica.